subject area of
- An international expanded-access programme of everolimus: Addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy Journal Articles
- Clinical utility of optical coherence tomography (OCT) in the optimisation of Absorb bioresorbable vascular scaffold deployment during percutaneous coronary intervention. Journal Articles
- Effectiveness of Adding Everolimus to the First-line Treatment of Advanced Breast Cancer in Premenopausal Women Who Experienced Disease Progression While Receiving Selective Estrogen Receptor Modulators Journal Articles
- Efficacy and Safety of a Novel Bioabsorbable Polymer-Coated, Everolimus-Eluting Coronary Stent Journal Articles
- Everolimus and pazopanib (E/P) benefit genomically selected patients with metastatic urothelial carcinoma Journal Articles
- Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Disease Journal Articles
- Metabolomic adaptations and correlates of survival to immune checkpoint blockade Journal Articles
- Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition Journal Articles
- PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer Journal Articles
- Randomized Phase II Study Comparing Two Schedules of Everolimus in Patients With Recurrent/Metastatic Breast Cancer: NCIC Clinical Trials Group IND.163 Conferences
- SYNERGY—Everolimus-Eluting Stent With a Bioabsorbable Polymer in ST-Elevation Myocardial Infarction: CLEAR SYNERGY OASIS-9 Registry Conferences
- Surgical biology for the clinician: vascular effects of immunosuppression. Journal Articles
- Targeted therapy for metastatic renal cell carcinoma Journal Articles